Alzamend Neuro (ALZN) Times Interest Earned (2020 - 2026)
Alzamend Neuro's Times Interest Earned was -1508.93 in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -1087.48 a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Times Interest Earned (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Times Interest Earned was -1480.55 through Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it came in at -1324.50.
- In earlier fiscal years, Times Interest Earned was -249.42 in FY2025, -983.83 in FY2024, -1930.98 in FY2023 and -264.80 in FY2022.
- Quarterly Times Interest Earned has moved between -19139.18 (fiscal Q4 2026) and -80.16 (fiscal Q1 2025) over five years.
- Per Business Quant data, ALZN's Times Interest Earned in the three fiscal quarters before Q1 2027 was -19139.18 (Q4 2026), -1643.72 (Q3 2026) and -376.79 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | -1,508.93 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -1,508.93 |
| Apr 30, 2026 | -19,139.18 |
| Jan 31, 2026 | -1,643.72 |
| Oct 31, 2025 | -376.79 |
| Jul 31, 2025 | -1,087.48 |
| Apr 30, 2025 | -2,237.60 |
| Jan 31, 2025 | -513.83 |
| Oct 31, 2024 | -388.57 |
| Jul 31, 2024 | -80.16 |
| Apr 30, 2024 | -580.25 |
| Jan 31, 2024 | -1,069.10 |
| Oct 31, 2023 | -673.10 |
| Jul 31, 2023 | -1,921.49 |
| Apr 30, 2023 | -6,368.03 |
| Jan 31, 2023 | -2,630.22 |
| Oct 31, 2022 | -865.78 |
| Jul 31, 2022 | -1,981.42 |
| Apr 30, 2022 | -6,433.22 |
| Jan 31, 2022 | -156.85 |
| Oct 31, 2021 | -224.07 |
API Access
Alzamend Neuro Times Interest Earned API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "times-interest-earned", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();